FIELD: biotechnology.
SUBSTANCE: invention relates to a method of increasing the phagocytic activity of macrophages. The method involves exposing macrophages to graphene oxide nanoparticles obtained by electrochemical exfoliation of working electrodes from highly oriented pyrolytic graphite and diluted with phosphate-buffered saline to obtain a graphene oxide concentration of 1 mg/ml, while the resulting suspension is added to the cell monolayer of macrophages at a final concentration of 2 μg/ml of medium to prevent cell necrosis, cells are cultured in the presence of graphene oxide for 2 hours, after which they are washed.
EFFECT: invention is effective for increasing the effectiveness of biotechnological vaccines based on macrophages.
1 cl, 1 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| MODIFIED MONOCYTES/MACROPHAGES EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND THEIR APPLICATIONS | 2016 |
|
RU2766690C2 |
| USE OF PROSTAGLANDIN E1 (ALPROSTADIL) FOR ACTIVATION OF ANTITUMOUR ACTIVITY OF MACROPHAGES | 2024 |
|
RU2832882C1 |
| METHOD FOR ASSESSING PHAGOCYTIC ACTIVITY OF NEUTROPHILS | 2023 |
|
RU2824345C1 |
| METHOD FOR ANALYZING EFFECTIVENESS OF PHAGOCYTOSIS | 2023 |
|
RU2831297C1 |
| PHAGOCYTIC CELL SORTING METHOD | 2024 |
|
RU2835814C1 |
| NK CELL LINE EXPRESSING PSMA-SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND SECRETING CD47/SIRPA INTERACTION BLOCKER | 2020 |
|
RU2757353C1 |
| METHOD OF SUBCUTANEOUS TRANSPLANT GROWTH INHIBITION OF EXPERIMENTAL HUMAN GLIOBLASTOMA U-87, TRANSPLANTED TO IMMUNODEFICIENT MICE Nu/J | 2019 |
|
RU2717218C1 |
| AGENT OF HUMIC NATURE, WHICH ENHANCES PHAGOCYTIC ACTIVITY OF CELLS | 2023 |
|
RU2834961C1 |
| METHOD OF SELECTING MEDICINAL PRODUCTS FOR PHARMACOLOGICAL INDUCTION OF MITOCHONDRIAL DYSFUNCTION IN MACROPHAGES FOR ANTITUMOR THERAPY | 2023 |
|
RU2810558C1 |
| METHOD OF TUMOUR GROWTH INHIBITION BASED ON IN VITRO REPROGRAMMING MACROPHAGES ON M1 PHENOTYPE WITH HIGH ABILITY OF NITRIC OXIDE PRODUCTION IN EXPERIMENT | 2015 |
|
RU2599545C1 |
